Wells Fargo analyst Derek Archila upgraded Celldex to Overweight from Equal Weight with a $44 price target. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on CLDX: SAP under DOJ probe, Adobe sees record holiday season sales: Morning Buzz Celldex barzolvolimab data above expectations, says Wolfe Research Celldex trading resumes Celldex trading halted, volatility trading pause Celldex presents 52 week results from barzolvolimab Phase 2 study Disclaimer & DisclosureReport an Issue
